Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment
Status:
Unknown status
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This pilot study is crucial to determining whether treating individuals who are at high risk
for transmission or re-infection will impact HCV reinfection rates. It will establish the
feasibility of DAA treatment in corrections facilities, as well as delineate the underlying
immune basis of HCV cure and reinfection.